Alantolactone

Alantolactone is a lipid of Prenol Lipids (PR) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 323 references associated with Alantolactone in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Alantolactone

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Alantolactone

MeSH term MeSH ID Detail
Dermatitis, Contact D003877 59 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Total 2

NCBI Entrez Crosslinks

All references with Alantolactone

Download all related citations
Per page 10 20 50 100 | Total 75
Authors Title Published Journal PubMed Link
Ding Y et al. Induction of ROS Overload by Alantolactone Prompts Oxidative DNA Damage and Apoptosis in Colorectal Cancer Cells. 2016 Int J Mol Sci pmid:27089328
Rezeng C et al. Alantolactone exhibited anti-herpes simplex virus 1 (HSV-1) action in vitro. 2015 Biosci Trends pmid:26781801
Xu R et al. Pharmacokinetics, tissue distribution and excretion of isoalantolactone and alantolactone in rats after oral administration of Radix Inulae extract. 2015 Molecules pmid:25927901
Mi XG et al. Alantolactone induces cell apoptosis partially through down-regulation of testes-specific protease 50 expression. 2014 Toxicol. Lett. pmid:24252419
Alzoubi K et al. Triggering of programmed erythrocyte death by alantolactone. 2014 Toxins (Basel) pmid:25533522
Wei W et al. Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion. 2013 Apoptosis pmid:23613107
Khan M et al. Alantolactone induces apoptosis in HepG2 cells through GSH depletion, inhibition of STAT3 activation, and mitochondrial dysfunction. 2013 Biomed Res Int pmid:23533997
Yang C et al. Alantolactone inhibits growth of K562/adriamycin cells by downregulating Bcr/Abl and P-glycoprotein expression. 2013 IUBMB Life pmid:23441067
Zhang Y et al. Alantolactone induces apoptosis in RKO cells through the generation of reactive oxygen species and the mitochondrial pathway. 2013 Mol Med Rep pmid:23970102
Rasul A et al. Targeting apoptosis pathways in cancer with alantolactone and isoalantolactone. 2013 ScientificWorldJournal pmid:24288468